Trial intelligence / Profile preview

Dexmedetomidine and postoperative renal function in adult living donor liver transplantation

KCT0003220Phase 4Completed

Sponsor
Asan Medical Center
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in decompensated cirrhosis, sponsored by Asan Medical Center. Primary endpoint: Postoperative renal function. Started Jul 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

decompensated cirrhosis

Beyond the preview

Go deeper on KCT0003220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call